During the past decade, Clinique de la Mémoire de l'Outaouais conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 4 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 4 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique de la Mémoire de l'Outaouais" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "AstraZeneca" with 2 trials sponsored, "Cassava Sciences, Inc." with 2 trials sponsored, "Alzheon Inc." with 1 trials sponsored and "Biogen" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique de la Mémoire de l'Outaouais" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Clinique de la Mémoire de l'Outaouais" are "Alzheimer Disease" (8 trials), "Alzheimer's Disease" (2 trials), "Early Alzheimer's Disease" (2 trials), "Alzheimer Disease (AD)" (1 trials) and "Alzheimer´s Disease" (1 trials). Many other conditions were trialed in "Clinique de la Mémoire de l'Outaouais" in a lesser frequency.

Most popular intervention types in "Clinique de la Mémoire de l'Outaouais" are "Drug" (14 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Donanemab" (2 trials), "Lanabecestat" (2 trials), "Active Neuro RX Gamma device" (1 trials) and "Aducanumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique de la Mémoire de l'Outaouais" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Clinique de la Mémoire de l'Outaouais". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Clinique de la Mémoire de l'Outaouais, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique de la Mémoire de l'Outaouais, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Clinique de la Mémoire de l'Outaouais has several departments that took part in Clinical trials: "Recherches Neuro-Hippocampe" - 2 trials